Aberdeen Group plc

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1716774 EDINBURGH, X0

Position in CRNX

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$30,699,180

+$902,434 QoQ

Shares Held

820,395

0.0% QoQ

Ownership

0.773%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#35

of 266 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Aberdeen Group plc holds $1,997,986,618 across 85 Biotechnology names. CRNX ranks #22 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MANE	Veradermics, Inc	1,096,642	$134,821,167
2	QURE	uniQure N.V.	2,848,117	$131,184,269
3	VRTX	Vertex Pharmaceuticals Inc / Ma	210,601	$104,611,833
4	ARGX	Argenx SE	83,822	$77,767,536
5	ABVX	Abivax S.A.	522,025	$69,565,051
6	REGN	Regeneron Pharmaceuticals, Inc.	101,566	$63,330,462
7	ORKA	Oruka Therapeutics, Inc.	646,943	$61,569,565
8	INSM	INSMED Inc	577,437	$61,566,331

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$30,699,180	820,395	0.0%	Shares	Defined	2026-07-31
2026-03-31	$29,796,746	820,395	+21.6%	Shares	Defined	2026-04-29
2025-12-31	$31,399,511	674,533	+98.4%	Shares	Defined	2026-01-16
2025-09-30	$14,158,875	339,949	+21.3%	Shares	Defined	2025-11-07
2025-06-30	$8,062,779	280,347	+34.7%	Shares	Defined	2025-07-24
2025-03-31	$6,978,298	208,059	+379.5%	Shares	Defined	2025-05-13
2024-12-31	$2,218,479	43,389	+22.3%	Shares	Defined	2025-01-24
2024-09-30	$1,812,363	35,467	-46.4%	Shares	Defined	2024-10-25
2024-06-30	$2,964,918	66,196	-34.6%	Shares	Defined	2024-08-09
2024-03-31	$4,736,984	101,196	0.0%	Shares	Defined	2024-05-09
2023-12-31	$3,600,553	101,196	—	Shares	Defined	2024-01-31
No filing history on record for this holder in this stock.